Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypo-BEAR: Empagliflozin and Anakinra for Postprandial Hypoglycemia
NCT03200782Completed
- Sponsor
- University Hospital Basel
- Start
- May 2017
- Primary completion
- Sep 2018
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postprandial hypoglycemia comparing Empagliflozin, Anakinra and Placebo (3 arms). Primary endpoint: Postprandial hypoglycemia in patients after bariatric surgery at 6 hours. Started May 2017; status: completed.
02
Drugs
empagliflozinanakinra
03
Conditions
postprandial hypoglycemia
Beyond the preview
Go deeper on NCT03200782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03200782.